Antegenes

About:

Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.

Website: https://antegenes.com/

Top Investors: Enterprise Estonia, EIT - European Institute of Innovation and Technology, Aare Kurist, Peep Vain, Timo Rein

Description:

Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detection measures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.